{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T15:45:57Z","timestamp":1789919157236,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018955","name":"Leeds Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.autrev.2023.103405","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T10:24:46Z","timestamp":1691058286000},"page":"103405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis"],"prefix":"10.1016","volume":"23","author":[{"given":"Dennis","family":"McGonagle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ramonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Scagnellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Scriffignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake","family":"Weddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennio","family":"Lubrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2023.103405_bb0005","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11926-012-0274-2","article-title":"Current concept of spondyloarthritis: special emphasis on early referral and diagnosis","volume":"14","author":"Ozgocmen","year":"2012","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.autrev.2023.103405_bb0010","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1136\/ard.2009.108233","article-title":"The development of assessment of SpondyloArthritis international society classification criteria for axial spondyloarthritis [part II]: validation and final selection","volume":"68","author":"Rudwaleit","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/art.37803","article-title":"Review: nonradiographic axial spondyloarthritis: new definition of an old disease?","volume":"65","author":"Sieper","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s13075-016-0977-2","article-title":"Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey","volume":"18","author":"Ramonda","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2023.103405_bb0025","first-page":"1","article-title":"Relationship between sex and clinical and imaging features of early axial spondyloarthritis: results from a 48 month follow-up [Italian arm of the SPondyloArthritis caught early [SPACE] study]","author":"Lorenzin","year":"2023","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2023.103405_bb0030","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0363546504267153","article-title":"Bone stress injuries in asymptomatic elite recruits: a clinical and magnetic resonance imaging study","volume":"33","author":"Kiuru","year":"2005","journal-title":"Am J Sports Med"},{"key":"10.1016\/j.autrev.2023.103405_bb0035","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2023.103405_bb0040","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/annrheumdis-2020-218669","article-title":"Which factors are associated with bone marrow oedema suspicious of axial spondyloarthritis as detected by MRI in the sacroiliac joints and the spine in the general population?","volume":"80","author":"Baraliakos","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/ard-2022-223296","article-title":"ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update","volume":"82","author":"Ramiro","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2017-211734","article-title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","volume":"77","author":"Smolen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12891-015-0620-4","article-title":"Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab","volume":"16","author":"Lorenzin","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.autrev.2023.103405_bb0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/OARRR.S295033","article-title":"Therapeutic targets for ankylosing spondylitis - recent insights and future prospects","volume":"14","author":"Perrotta","year":"2022","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.autrev.2023.103405_bb0065","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/1744666X.2021.1825941","article-title":"Multimorbidity and comorbidity in psoriatic arthritis - a perspective","volume":"16","author":"Lubrano","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2023.103405_bb0070","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1007\/s40744-020-00229-0","article-title":"Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study","volume":"7","author":"Lubrano","year":"2020","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2023.103405_bb0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41584-020-00541-7","article-title":"Persistent inflammatory and non-inflammatory mechanisms in refractory rheumatoid arthritis","volume":"17","author":"Buch","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103405_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/annrheumdis-2020-217344","article-title":"EULAR definition of difficult-to-treat rheumatoid arthritis","volume":"80","author":"Nagy","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0085","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s40744-022-00461-w","article-title":"Clinical characteristics of potential \u201cdifficult-to-treat\u201d patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort","volume":"9","author":"Perrotta","year":"2022","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2023.103405_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105512","article-title":"Is the difficult-to-treat [D2T] concept applicable to axial spondyloarthritis?","volume":"90","author":"Wendling","year":"2023","journal-title":"Joint Bone Spine"},{"issue":"Suppl. 9","key":"10.1016\/j.autrev.2023.103405_bb0095","article-title":"Difficult to treat Spondyloarthritis: patients with a high biologic switch rate and the factors influencing it; a real world as clinic experience [abstract]","volume":"74","author":"Dua","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.autrev.2023.103405_bb0100","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3899\/jrheum.140811","article-title":"Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-\u03b1 drugs: an Italian multicenter study","volume":"42","author":"Lubrano","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2023.103405_bb0105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/acr.24174","article-title":"The phenotype of axial Spondyloarthritis: is it dependent on HLA-B27 status?","volume":"73","author":"Coates","year":"2021","journal-title":"Arthritis Care Res [Hoboken]"},{"key":"10.1016\/j.autrev.2023.103405_bb0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.220309","article-title":"Management of Axial Disease in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations","volume":"50","author":"Lubrano","year":"2023","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2023.103405_bb0115","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/art.24408","article-title":"Clinical and imaging efficacy of infliximab in HLA-B27-positive patients with magnetic resonance imaging-determined early sacroiliitis","volume":"60","author":"Barkham","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0120","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-135-9-200111060-00012","article-title":"Clinical inertia","volume":"135","author":"Phillips","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2023.103405_bb0125","first-page":"kead262","article-title":"A prospective survey on therapeutic inertia in psoriatic arthritis [OPTI\u2019PsA]","author":"Liot\u00e9","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2023.103405_bb0130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40744-022-00514-0","article-title":"Sequencing of biologic and target synthetic disease-modifying anti-rheumatic drugs in psoriatic arthritis: are we ready to redefine the treatment strategy? A perspective","volume":"10","author":"Lubrano","year":"2022","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.autrev.2023.103405_bb0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","article-title":"Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and Haemopoietic stem cell transplantation","volume":"102","author":"Blad\u00e9","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2023.103405_bb0140","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/annrheumdis-2012-203201","article-title":"Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, part 1","volume":"73","author":"Sieper","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"10142","key":"10.1016\/j.autrev.2023.103405_bb0145","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0140-6736(18)31362-X","article-title":"Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study","volume":"392","author":"Landew\u00e9","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.autrev.2023.103405_bb0150","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/annrheumdis-2012-201766","article-title":"Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial [ABILITY-1]","volume":"72","author":"Sieper","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2023.103405_bb0155","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/art.33465","article-title":"Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis","volume":"64","author":"Poddubnyy","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2023.103405_bb0160","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/acr.21688","article-title":"Do patients with non-radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?","volume":"64","author":"Kiltz","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2023.103405_bb0165","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","article-title":"The European Spondylarthropathy study group preliminary criteria for the classification of spondylarthropathy","volume":"34","author":"Dougados","year":"1991","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0170","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41584-019-0221-y","article-title":"Therapeutic options for targeting inflammatory osteoarthritis pain","volume":"15","author":"Conaghan","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2023.103405_bb0175","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.ijo.0802609","article-title":"Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome","volume":"28","author":"Aronson","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.autrev.2023.103405_bb0180","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1159\/000455840","article-title":"Psoriasis and obesity","volume":"232","author":"Jensen","year":"2016","journal-title":"Dermatology"},{"key":"10.1016\/j.autrev.2023.103405_bb0185","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.10125","article-title":"The role of biomechanical factors and HLA-B27 in magnetic resonance imaging-determined bone changes in plantar fascia enthesopathy","volume":"46","author":"McGonagle","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0190","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1136\/annrheumdis-2015-208642","article-title":"Defining active sacroiliitis on MRI for classification of axial spondyloarthritis: update by the ASAS MRI working group","volume":"75","author":"Lambert","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0195","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/jamadermatol.2019.4029","article-title":"Comparison of biologics and Oral treatments for plaque psoriasis: a Meta-analysis","volume":"156","author":"Armstrong","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.autrev.2023.103405_bb0200","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ard-2022-223298","article-title":"Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis","volume":"82","author":"Webers","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2023.103405_bb0205","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/1529-0131(200109)44:9<2112::AID-ART363>3.0.CO;2-H","article-title":"Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: a clinical and magnetic resonance imaging study","volume":"44","author":"Marzo-Ortega","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0210","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/art.22290","article-title":"Microdamage and altered vascularity at the enthesis-bone interface provides an anatomic explanation for bone involvement in the HLA-B27-associated spondylarthritides and allied disorders","volume":"56","author":"Benjamin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2023.103405_bb0215","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0140-6736(97)02135-1","article-title":"Nerve ingrowth into diseased intervertebral disc in chronic back pain","volume":"350","author":"Freemont","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2023.103405_bb0220","article-title":"Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohortRMD","volume":"4","author":"de Bruin","year":"2018","journal-title":"Open"},{"key":"10.1016\/j.autrev.2023.103405_bb0225","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1007\/s00296-020-04621-5","article-title":"The prevalence of fibromyalgia in axial spondyloarthritis","volume":"40","author":"Jones","year":"2020","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2023.103405_bb0230","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/annrheumdis-2017-211596","article-title":"Sacroiliac radiographic progression in recent onset axial spondyloarthritis: the 5-year data of the DESIR cohort","volume":"76","author":"Dougados","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2023.103405_bb0235","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2023.103405_bb0240","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"\u2018MHC-I-opathy\u2019-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2023.103405_bb0245","first-page":"88","article-title":"Real world \u201cpoly-refractory RA\u201d: a rare but unmet clinical challenge [abstract]","volume":"82","author":"David","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997223001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T10:28:24Z","timestamp":1729160904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997223001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1568997223001398"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103405","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2023.103405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103405"}}